Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

This study has been terminated.
(The study drugs are not covered anymore by insurance.)
Sponsor:
Information provided by:
National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT00506168
First received: July 23, 2007
Last updated: NA
Last verified: July 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given